Decline in US breast cancer rates after the Women's Health Initiative: socioeconomic and racial/ethnic differentials (Q82859669)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20147667%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Decline in US breast cancer rates after the Women's Health Initiative: socioeconomic and racial/ethnic differentials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20147667%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Nancy Krieger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20147667%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jarvis T Chen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20147667%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Pamela D Waterman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20147667%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

10 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20147667%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Public Health

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20147667%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

100 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20147667%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

S132-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20147667%20AND%20SRC:MED&resulttype=core&format=json

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

18 January 2020

cites work

1 reference

12 December 2020

Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy

1 reference

12 December 2020

Commentary: hormone replacement therapy and coronary heart disease: four lessons

1 reference

12 December 2020

Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology

1 reference

12 December 2020

Hormonal chemoprevention of cancer in women

1 reference

12 December 2020

Epidemiology and prevention of breast cancer

1 reference

12 December 2020

Hormone replacement therapy and major risk factors for reproductive cancers, osteoporosis, and cardiovascular diseases: evidence of confounding by exposure characteristics.

1 reference

12 December 2020

Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results

1 reference

12 December 2020

Permutation tests for joinpoint regression with applications to cancer rates

1 reference

12 December 2020

Can we monitor socioeconomic inequalities in health? A survey of U.S. health departments' data collection and reporting practices.

1 reference

12 December 2020

Hormonal contraception and chemoprevention of female cancers

1 reference

12 December 2020

The relationship of race/ethnicity and social class to hormone replacement therapy: results from the Third National Health and Nutrition Examination Survey 1988-1994

1 reference

12 December 2020

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

The declining impact of race and insurance status on hormone replacement therapy

1 reference

12 December 2020

Age standardization of death rates: implementation of the year 2000 standard.

1 reference

12 December 2020

Socioeconomic Position and Hormone Replacement Therapy Use: Explaining the Discrepancy in Evidence From Observational and Randomized Controlled Trials

1 reference

12 December 2020

Comparability of segmented line regression models.

1 reference

12 December 2020

Painting a truer picture of US socioeconomic and racial/ethnic health inequalities: the Public Health Disparities Geocoding Project

1 reference

12 December 2020

Use of menopausal hormones in the United States, 1992 through June, 2003.

1 reference

12 December 2020

Ethnicity and breast cancer: factors influencing differences in incidence and outcome

1 reference

12 December 2020

Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives

1 reference

12 December 2020

Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income

1 reference

12 December 2020

Trends in breast cancer by race and ethnicity: update 2006.

1 reference

12 December 2020

Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.

1 reference

12 December 2020

Monitoring socioeconomic disparities in death: comparing individual-level education and area-based socioeconomic measures.

1 reference

12 December 2020

Steroid receptors and their role in the biology and control of breast cancer growth

1 reference

12 December 2020

Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies

1 reference

12 December 2020

The decrease in breast-cancer incidence in 2003 in the United States

1 reference

12 December 2020

Decline in breast cancer incidence--United States, 1999-2003.

1 reference

12 December 2020

Declines in breast cancer after the WHI: apparent impact of hormone therapy

1 reference

12 December 2020

Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women

1 reference

12 December 2020

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

1 reference

12 December 2020

Commentary: ways of asking and ways of living: reflections on the 50th anniversary of Morris' ever-useful Uses of Epidemiology

1 reference

12 December 2020

Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.

1 reference

12 December 2020

Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy

1 reference

12 December 2020

Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype

1 reference

12 December 2020

The fall and rise of US inequities in premature mortality: 1960-2002

1 reference

12 December 2020

Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer.

1 reference

12 December 2020

Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia

1 reference

12 December 2020

Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections

1 reference

12 December 2020

Declining breast cancer incidence and decreased HRT use.

1 reference

12 December 2020

Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions

1 reference

12 December 2020

Breast cancer after use of estrogen plus progestin in postmenopausal women

1 reference

12 December 2020

Revisiting Robinson: the perils of individualistic and ecologic fallacy

1 reference

12 December 2020

Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy?

1 reference

12 December 2020

Reduced use of hormones and the drop in breast cancer

1 reference

12 December 2020

Hormonal aspects in the causation of human breast cancer: epidemiological hypotheses reviewed, with special reference to nutritional status and first pregnancy

1 reference

12 December 2020

Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration

1 reference

12 December 2020

Estrogen carcinogenesis in breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.2105/AJPH.2009.181628

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20147667%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20147667%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

PubMed publication ID

20147667

1 reference